|Articles|January 1, 2002

January 2002
Volume 8
Issue 1

The Generalist's Patient and the Subspecialist

Author(s)Stanley Reichman, MD

Download PDF: The Generalist's Patient and the Subspecialist

Articles in this issue

over 24 years ago

Article

TennCare - Medicaid Managed Care in Tennessee in Jeopardy

over 24 years ago

Article

Effects of Restrictive Formularies in the Ambulatory Care Setting

over 24 years ago

Article

Postmenopausal Hormone Replacement Therapy and Major Clinical Outcomes: A Focus on Cardiovascular Disease, Osteoporosis, Dementia, and Breast and Endometrial Neoplasia

over 24 years ago

Article

Can Guidelines Impact the Ordering of Magnetic Resonance Imaging Studies by Primary Care Providers for Low Back Pain?

over 24 years ago

Article

Accuracy of Computerized Outpatient Diagnoses in a Veterans Affairs General Medicine Clinic

over 24 years ago

Article

Issues in Pooling Administrative Data for Economic Evaluation

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

The Generalist's Patient and the Subspecialist

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

Trump Announces Timeline for 100% Generic Drug Tariffs Beginning in 2028, 200% in 2029

FDA Advisory Panel Weighs Access to 7 Popular Peptides This Week

Eplontersen Misses Primary End Point in Phase 3 ATTR-CM Cardiovascular Outcomes Trial

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Dermatology Practices Absorb Rising Prior Authorization Costs